Core Viewpoint - TELUS Corporation announced a partial redemption of C$500 million of its 2.75% Notes, Series CZ, due July 8, 2026, which will be funded through proceeds from its Fixed-to-Fixed Rate Junior Subordinated Notes offerings completed in December 2025 [1]. Group 1: Financial Details - The total outstanding amount of the 2.75% Notes, Series CZ, is C$800 million, indicating that the partial redemption will affect 62.5% of the total outstanding notes [1]. - The redemption will occur on May 8, 2026, and will be conducted on a pro rata basis [1]. Group 2: Company Overview - TELUS operates in over 45 countries and generates more than $20 billion in annual revenue, with over 21 million customer connections [1]. - The company is focused on leveraging technology to enhance human outcomes and is committed to client service excellence and social capitalism [1]. - TELUS Health has positively impacted over 161 million lives across 200 countries through innovative health technologies [1]. - The company has contributed $1.85 billion in cash and in-kind contributions since 2000, earning recognition as the world's most giving company [1].